Clinical Trial Update: Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 randomized study comparing paliperidone extended-release with risperidone in schizophrenia to assess neurocognitive function; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• INVEGA (PALIPERIDONE)
• Risperdal (risperidone)

Snippet

Sponsor: Chonnam National University Hospital | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED